# Sioxmed, LLC

- Location (FDA's records): Clemmons, NC
- FDA decisions: 5 (2022–2026): 5 510(k) clearances
- Product codes: QSZ (3), FRO (2)
- Predicates its devices cite: 7 (4 its own); citations of its devices by later devices: 4 (4 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Engineered Tissue Solutions, LLC: 1 (https://510kreport.com/company/engineered-tissue-solutions)
- Beeken Biomedical, LLC: 1 (https://510kreport.com/company/beeken-biomedical)
- Ceragenix Corporation: 1 (https://510kreport.com/company/ceragenix)

## Its most-cited devices
- K222189: SiOxD Wound Matrix (2022), cited by 2
- K242406: SiOxC Cream (2025), cited by 1
- K232847: SiOxD Wound Matrix (2023), cited by 1

## Recent decisions
- K250890: SBC1 Cream (Jan 12, 2026)
- K242406: SiOxC Cream (Mar 13, 2025)
- K241660: SiOxD® Wound Matrix (Jul 5, 2024)
- K232847: SiOxD Wound Matrix (Dec 18, 2023)
- K222189: SiOxD Wound Matrix (Nov 18, 2022)

Source page: https://510kreport.com/company/sioxmed